바로가기메뉴

본문 바로가기 주메뉴 바로가기

Reference

1.

(2006) Gender differentials of pulmonary tuberculosis transmission and reactivation in an endemic area,

2.

(2001) Attention to gender issues in tuberculosis control,

3.

(2004) Gender disparities in tuberculosis report from a rural DOTS programme in south India,

4.

(2002) Risk factors for pulmonary tuberculosis in Estonia,

5.

(2000) Analysis of Mycobacterium tuberculosis transmission patterns in a homeless shelter outbreak,

6.

(20004) The role of core groups in transmitting Mycobacterium tuberculosis in a high prevalence community in Southern Mexico,

7.

(2004) Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part II: Determinants operating at environmental and institutional level,

8.

(2004) Tuberculosis and diabetes in southern Mexico,

9.

(2000) Incidence and prognosis of tuberculosis in patients with cirrhosis of the liver,

10.

(2007) Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the western Cape of South Africa,

11.

Godfrey-Faussett P, (2000) Tuberculosis control and molecular epidemiology in a South African gold- mining community,

12.

Garcia-Garcia ML, (2000) Clinical consequences and transmissibility of drug-resistant tuberculosis in southern Mexico,

13.

Kruuner A, (2001) Spread of drug-resistant pulmonary tuberculosis in Estonia,

14.

Teixeira L, (2001) Infection and disease among household contacts of patients with multidrug- resistant tuberculosis,

15.

van Soolingen D, (2000) Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands,

16.

Pym AS, (2002) Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans,

17.

(2006) Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness,

18.

(intjepidemiol1993;22) Protective effect of BCG against tuberculous meningitis and miliary tuberculosis,

19.

(jama1994;271) Efficacy of BCG vaccine in the prevention of tuberculosis Meta- analysis of the published literature,

20.

(2006) Comparison of two commercial interferon- gamma assays for diagnosing Mycobacterium tuberculosis infection,

21.

(2000) Targeted tuberculin testing and treatment of latent tuberculosis infection,

22.

(2005) Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country,

23.

(2001) Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells,

24.

(2006) Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis,

25.

(2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent,

26.

(2006) Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum,

27.

(2005) Mycobacterium kansasii pulmonary diseases in Korea,

28.

(2005) Recovery rate of NTM from AFB smear- positive sputum specimens at a medical centre in South Korea,

29.

(2007) Role of the C-reactive protein for the diagnosis of TB among military personnel in South Korea,

30.

(jclinmicrobiol1983;18) Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear- positive specimens,

31.

(1987milmed1990;155) The investigation of a tuberculosis outbreak in the closed environment of a U,

32.

The epidemiology of tuberculosis infection in a closed environment,

33.

(2006) Microscopic-observation drug-susceptibility assay for the diagnosis of TB,

34.

(2007) The interval between initiation of anti- tuberculosis treatment in patients with culture- positive pulmonary tuberculosis and receipt of drug-susceptibility test results,

35.

(2006) Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis,

36.

(2004) Programmes and principles in treatment of multidrug-resistant tuberculosis,

37.

(2005) Impact of fluoroquinolones on the diagnosis of pulmonary tuberculosis initially treated as bacterial pneumonia,

38.

(2004) Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study,

39.

(2006) Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosis,

40.

(2004) Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis,

41.

(2002) A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis,

42.

(2001) Pulmonary resection for multi-drug resistant tuberculosis,

43.

(2001) Pulmonary resection in the treatment of patients with pulmonary multidrug-resistant tuberculosis in Taiwan,

44.

(1999) Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis,

45.

(1997) Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis,

46.

(1997) Role of surgery in multi-drug-resistant tuberculosis: results of 27 cases,

47.

(1995) Current role of surgery in Mycobacterium tuberculosis,

48.

(2004) Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis,

49.

(2001) The treatment of multidrug- resistant tuberculosis in Turkey,

50.

(2006) Extensively drug- resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa,

51.

(2006) Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004,

52.

(2006) XDR-TB: entering the post-antibiotic era? ,

Tuberculosis & Respiratory Diseases